These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2297712

  • 1. Role of bone marrow transplantation in 90Y antibody therapy of colon cancer xenografts in nude mice.
    Morton BA, Beatty BG, Mison AP, Wanek PM, Beatty JD.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):1008s-1010s. PubMed ID: 2297712
    [Abstract] [Full Text] [Related]

  • 2. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM.
    Cancer Res; 1988 Jun 01; 48(11):3270-5. PubMed ID: 3365705
    [Abstract] [Full Text] [Related]

  • 4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrier.
    Vallera DA, Schmidberger H, Buchsbaum DJ, Everson P, Snover DC, Blazar BR.
    Cancer Res; 1991 Apr 01; 51(7):1891-7. PubMed ID: 2004372
    [Abstract] [Full Text] [Related]

  • 6. Interferon enhancement of radioimmunotherapy for colon carcinoma.
    Kuhn JA, Beatty BG, Wong JY, Esteban JM, Wanek PM, Wall F, Buras RR, Williams LE, Beatty JD.
    Cancer Res; 1991 May 01; 51(9):2335-9. PubMed ID: 1901760
    [Abstract] [Full Text] [Related]

  • 7. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
    Ito T, Qiu H, Collins JA, Brill AB, Johnson DK, Griffin TW.
    Cancer Res; 1991 Jan 01; 51(1):255-60. PubMed ID: 1988087
    [Abstract] [Full Text] [Related]

  • 8. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
    Esteban JM, Kuhn JA, Felder B, Wong JY, Battifora H, Beatty JD, Wanek PM, Shively JE.
    Cancer Res; 1991 Jul 15; 51(14):3802-6. PubMed ID: 2065334
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.
    Esteban JM, Hyams DM, Beatty BG, Merchant B, Beatty JD.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):989s-992s. PubMed ID: 2297752
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC, Washburn LC, Sun TT, Byrd BL, Crook JE, Holloway EC, Steplewski Z.
    Cancer Res; 1990 Aug 01; 50(15):4546-51. PubMed ID: 2164441
    [Abstract] [Full Text] [Related]

  • 11. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM.
    Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228
    [Abstract] [Full Text] [Related]

  • 12. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 13. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB, Langmuir VK, Mendonca HL, Goris ML, Knox SJ.
    Cancer Res; 1993 Jul 01; 53(13):3022-7. PubMed ID: 8319209
    [Abstract] [Full Text] [Related]

  • 14. Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation.
    Blumenthal RD, Sharkey RM, Forman D, Wong G, Hess J, Goldenberg DM.
    Exp Hematol; 1995 Sep 01; 23(10):1088-97. PubMed ID: 7656929
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 16. Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of the T cell lymphoma EL4.
    Schmidberger H, Buchsbaum DJ, Blazar BR, Everson P, Vallera DA.
    Cancer Res; 1991 Apr 01; 51(7):1883-90. PubMed ID: 2004371
    [Abstract] [Full Text] [Related]

  • 17. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski S, Wu AM, Shively JE, Doroshow JH, Raubitschek AA.
    Clin Cancer Res; 2000 Oct 01; 6(10):3855-63. PubMed ID: 11051230
    [Abstract] [Full Text] [Related]

  • 18. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
    Stein R, Juweid M, Zhang CH, Goldenberg DM.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3199s-3206s. PubMed ID: 10541364
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
    Goodwin DA, Meares CF, Watanabe N, McTigue M, Chaovapong W, Ransone CM, Renn O, Greiner DP, Kukis DL, Kronenberger SI.
    Cancer Res; 1994 Nov 15; 54(22):5937-46. PubMed ID: 7954426
    [Abstract] [Full Text] [Related]

  • 20. Prolongation of survival of nude mice bearing human colon cancer. Treatment with yttrium 90-labeled anti-carcinoembryonic antigen antibody.
    Hyams DM, Esteban JM, Beatty BG, Wanek PM, Beatty JD.
    Arch Surg; 1989 Feb 15; 124(2):175-9. PubMed ID: 2916938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.